SK7582000A3 - Use of tranexamic acid for the preparation of a human fibrinogen composition - Google Patents

Use of tranexamic acid for the preparation of a human fibrinogen composition Download PDF

Info

Publication number
SK7582000A3
SK7582000A3 SK758-2000A SK7582000A SK7582000A3 SK 7582000 A3 SK7582000 A3 SK 7582000A3 SK 7582000 A SK7582000 A SK 7582000A SK 7582000 A3 SK7582000 A3 SK 7582000A3
Authority
SK
Slovakia
Prior art keywords
fibrinogen
product
composition
concentration
human
Prior art date
Application number
SK758-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Debart Pere Ristol
Camison Ma Isabel Bravo
Rodriguez Jesus Fernandez
Original Assignee
Grifols Grupo Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grifols Grupo Sa filed Critical Grifols Grupo Sa
Publication of SK7582000A3 publication Critical patent/SK7582000A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Surgery (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK758-2000A 1999-05-31 2000-05-19 Use of tranexamic acid for the preparation of a human fibrinogen composition SK7582000A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009901175A ES2156731B1 (es) 1999-05-31 1999-05-31 Utilizacion del acido tranexamico para la preparacion de una composicion de fibrinogeno humano.

Publications (1)

Publication Number Publication Date
SK7582000A3 true SK7582000A3 (en) 2001-05-10

Family

ID=8308626

Family Applications (1)

Application Number Title Priority Date Filing Date
SK758-2000A SK7582000A3 (en) 1999-05-31 2000-05-19 Use of tranexamic acid for the preparation of a human fibrinogen composition

Country Status (7)

Country Link
EP (1) EP1057490A3 (fr)
JP (1) JP2001019644A (fr)
AR (1) AR024551A1 (fr)
ES (1) ES2156731B1 (fr)
HU (1) HUP0001841A2 (fr)
SK (1) SK7582000A3 (fr)
UY (1) UY26146A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2214967B1 (es) 2003-03-06 2005-06-16 Probitas Pharma, S.A Procedimiento para la eliminacion de virus en soluciones de fibrinogeno y fibrinogeno obtenido por dicho procedimiento.
RU2484817C1 (ru) * 2012-03-11 2013-06-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Астраханская государственная медицинская академия" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО АГМА Минздравсоцразвития России) Способ профилактики повышенной кровопотери и коагулопатического кровотечения при вагинальном родоразрешении в раннем послеродовом периоде
EP2695605B1 (fr) * 2012-08-07 2017-05-03 Parapharm Development Ltd. Composition d'acide tranexamique
KR101841587B1 (ko) * 2016-01-12 2018-05-14 주식회사 녹십자홀딩스 피브리노겐의 정제방법
CA3073685A1 (fr) 2017-08-27 2019-03-07 Anti-Viral Technologies, Llc Methodes et compositions pour l'utilisation antivirale d'analogues et de mimetiques synthetiques de lysine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2101811B (en) * 1981-06-30 1985-01-03 Racal Dana Instr Ltd Improvements in and relating to the screening of electrical circuit arrangements
DE3203775A1 (de) * 1982-02-04 1983-08-11 Behringwerke Ag, 3550 Marburg Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung
JPH08512215A (ja) * 1993-03-30 1996-12-24 オパーバス・ホールディング・ビー・ブイ 二成分フィブリングルー
GB9424732D0 (en) * 1994-12-08 1995-02-08 Common Services Agency Heat treated blood plasma proteins
EP0856317A1 (fr) * 1997-01-31 1998-08-05 Omrix Biopharmaceuticals S.A. Mélange stabilisé contenant du fibrinogène
AU8336098A (en) * 1997-06-05 1998-12-21 Omrix Biopharmaceuticals S.A. Fibrinogen concentrate from human plasma

Also Published As

Publication number Publication date
ES2156731B1 (es) 2002-02-16
ES2156731A1 (es) 2001-07-01
EP1057490A2 (fr) 2000-12-06
UY26146A1 (es) 2000-12-29
AR024551A1 (es) 2002-10-16
HUP0001841A2 (en) 2002-09-28
JP2001019644A (ja) 2001-01-23
EP1057490A3 (fr) 2002-04-03
HU0001841D0 (en) 2000-07-28

Similar Documents

Publication Publication Date Title
KR101082769B1 (ko) 저장 안정성의 액상 피브리노겐 제형
JP4278861B2 (ja) ウイルス汚染に対する安全性の高いフィブリンのり形成用成分をヒト血漿プールから製造する方法
RU2142290C1 (ru) Водный раствор фактора viii со сниженной концентрацией кислорода
JP5719266B2 (ja) ウイルス不活性化熱処理へ供するための血漿タンパク質の寒冷沈降物を安定化する方法
US5260420A (en) Concentrate of thrombin coagulable proteins, the method of obtaining same and therapeutical use thereof
FI104378B (fi) Menetelmä trombiinin valmistamiseksi
EP1151007B1 (fr) Procede de fabrication d'une preparation a base de fibrinogene et de fibronectine et compositions proteiques obtenues par ce procede
EP2130549B1 (fr) Préparation de fibrinogène solide
CN105899242B (zh) 包含聚合抑制剂的一组分纤维蛋白胶
JP3133338B2 (ja) ウイルス的に安全な生物学的組成物の調製方法
DK156698B (da) Fremgangsmaade til pasteurisering af et materiale indeholdende et termisk foelsomt, terapeutisk aktivtprotein valgt blandt alfa-l-antitrypsin, antithrombin-iii, praekallikrein, antihaemofil faktor (faktorviii) og fibronectin
JPH1036286A (ja) 貯蔵に安定なフィブリノーゲン調製物
JP2787317B2 (ja) トロンビン凝固性蛋白質の濃縮物、その製造方法及びその治療的用途
KR20040058194A (ko) 보관이 안정한 피브리노겐 용액
SK7582000A3 (en) Use of tranexamic acid for the preparation of a human fibrinogen composition
KR20040055782A (ko) 보관-안정한 인간 피브리노겐 용액
JP2010279739A (ja) フィブリノーゲンおよびフィブロネクチンをベースとする製剤を生成するための方法ならびにこの方法により入手可能なタンパク質組成物
CZ20001909A3 (cs) Použití tranexamové kyseliny pro výrobu prostředku lidského fibrinogenu a lidský fíbrinogenový prostředek
KR101162060B1 (ko) 건식 가열에 의한 바이러스 불활성화 방법
MXPA00004085A (en) Use of tranexamic acid for the preparation of a human fibrinogen composition
JPH05501417A (ja) 低温殺菌中の血漿安定化のための配合物
US20020146409A1 (en) Methods for stabilizing lyophilized blood proteins